Decision Diagnostics Corp. (DECN)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2022 | - USD | 0.0% |
| 2021 | - USD | 100.0% |
| 2020 | -2.11 Million USD | -63.12% |
| 2019 | -1.29 Million USD | 30.15% |
| 2018 | -1.85 Million USD | 21.63% |
| 2017 | -2.36 Million USD | 9.95% |
| 2016 | -2.62 Million USD | -32.33% |
| 2015 | -1.98 Million USD | 0.0% |
| 2012 | -2.7 Million USD | -168.24% |
| 2011 | -1 Million USD | -228.43% |
| 2010 | 784.3 Thousand USD | -14.56% |
| 2009 | 918 Thousand USD | 39.44% |
| 2008 | 658.34 Thousand USD | 158.37% |
| 2007 | -1.12 Million USD | 50.97% |
| 2006 | -2.3 Million USD | 33.32% |
| 2005 | -3.44 Million USD | -4.38% |
| 2004 | -3.3 Million USD | -67.3% |
| 2003 | -1.97 Million USD | -2.68% |
| 2002 | -1.92 Million USD | -384.13% |
| 2001 | -397.33 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q1 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2021 FY | - USD | 100.0% |
| 2021 Q2 | -237.36 Thousand USD | 47.72% |
| 2021 Q3 | -490.72 Thousand USD | -106.73% |
| 2021 Q1 | -454.01 Thousand USD | 39.5% |
| 2020 FY | -2.11 Million USD | -63.12% |
| 2020 Q1 | -607.17 Thousand USD | -1149.79% |
| 2020 Q2 | -407 Thousand USD | 32.97% |
| 2020 Q3 | -346.82 Thousand USD | 14.79% |
| 2020 Q4 | -750.43 Thousand USD | -116.38% |
| 2019 Q4 | 57.83 Thousand USD | 120.23% |
| 2019 Q3 | -285.92 Thousand USD | 25.3% |
| 2019 FY | -1.29 Million USD | 30.15% |
| 2019 Q2 | -382.75 Thousand USD | 44.47% |
| 2019 Q1 | -689.28 Thousand USD | -106.45% |
| 2018 Q1 | -519.74 Thousand USD | 50.19% |
| 2018 Q4 | -333.87 Thousand USD | 44.04% |
| 2018 FY | -1.85 Million USD | 21.63% |
| 2018 Q2 | -403.82 Thousand USD | 22.3% |
| 2018 Q3 | -596.62 Thousand USD | -47.74% |
| 2017 Q2 | -456.07 Thousand USD | -28.31% |
| 2017 Q1 | -355.43 Thousand USD | -154.06% |
| 2017 FY | -2.36 Million USD | 9.95% |
| 2017 Q4 | -1.04 Million USD | -71.72% |
| 2017 Q3 | -607.71 Thousand USD | -33.25% |
| 2016 Q3 | -981 Thousand USD | -84.45% |
| 2016 FY | -2.62 Million USD | -32.33% |
| 2016 Q4 | -139.9 Thousand USD | 85.74% |
| 2016 Q2 | -531.86 Thousand USD | 60.79% |
| 2016 Q1 | -1.35 Million USD | -179.04% |
| 2015 Q2 | -404.67 Thousand USD | 70.99% |
| 2015 Q4 | -486.06 Thousand USD | -174.67% |
| 2015 Q3 | -176.96 Thousand USD | 56.27% |
| 2015 Q1 | -1.39 Million USD | 0.0% |
| 2015 FY | -1.98 Million USD | 0.0% |
| 2014 Q2 | -349.21 Thousand USD | 19.74% |
| 2014 Q1 | -435.1 Thousand USD | 0.0% |
| 2013 Q3 | -601.95 Thousand USD | 62.87% |
| 2013 Q2 | -1.62 Million USD | -110.86% |
| 2013 Q1 | -768.93 Thousand USD | 58.77% |
| 2012 Q4 | -1.86 Million USD | -789.11% |
| 2012 Q2 | -626.72 Thousand USD | -61890.7% |
| 2012 Q3 | -209.75 Thousand USD | 66.53% |
| 2012 Q1 | -1011.00 USD | 99.92% |
| 2012 FY | -2.7 Million USD | -168.24% |
| 2011 Q4 | -1.21 Million USD | -513.28% |
| 2011 Q2 | 494.83 Thousand USD | 779.41% |
| 2011 Q1 | -72.83 Thousand USD | -704.25% |
| 2011 FY | -1 Million USD | -228.43% |
| 2011 Q3 | -197.55 Thousand USD | -139.92% |
| 2010 Q2 | 322.99 Thousand USD | 58.61% |
| 2010 Q3 | 268.49 Thousand USD | -16.87% |
| 2010 FY | 784.3 Thousand USD | -14.56% |
| 2010 Q4 | -9056.00 USD | -103.37% |
| 2010 Q1 | 203.63 Thousand USD | -55.7% |
| 2009 Q2 | 112.97 Thousand USD | -38.39% |
| 2009 Q3 | 161.96 Thousand USD | 43.36% |
| 2009 Q4 | 459.69 Thousand USD | 183.82% |
| 2009 FY | 918 Thousand USD | 39.44% |
| 2009 Q1 | 183.36 Thousand USD | -42.72% |
| 2008 Q2 | 140.51 Thousand USD | -4.1% |
| 2008 Q4 | 320.11 Thousand USD | 525.27% |
| 2008 Q3 | 51.19 Thousand USD | -63.56% |
| 2008 Q1 | 146.52 Thousand USD | 124.68% |
| 2008 FY | 658.34 Thousand USD | 158.37% |
| 2007 Q4 | -593.64 Thousand USD | -470.53% |
| 2007 Q3 | -104.05 Thousand USD | 40.36% |
| 2007 Q2 | -174.47 Thousand USD | 31.76% |
| 2007 Q1 | -255.68 Thousand USD | 83.17% |
| 2007 FY | -1.12 Million USD | 50.97% |
| 2006 Q2 | -384.91 Thousand USD | -423.36% |
| 2006 Q3 | -515.35 Thousand USD | -33.89% |
| 2006 Q4 | -1.51 Million USD | -194.72% |
| 2006 FY | -2.3 Million USD | 33.32% |
| 2006 Q1 | 119.03 Thousand USD | 107.87% |
| 2005 Q1 | -998.65 Thousand USD | -69.52% |
| 2005 Q2 | -355.49 Thousand USD | 64.4% |
| 2005 Q4 | -1.51 Million USD | -228.65% |
| 2005 Q3 | -460.31 Thousand USD | -29.49% |
| 2005 FY | -3.44 Million USD | -4.38% |
| 2004 FY | -3.3 Million USD | -67.3% |
| 2004 Q3 | -743.73 Thousand USD | 20.27% |
| 2004 Q2 | -932.85 Thousand USD | 8.75% |
| 2004 Q1 | -1.02 Million USD | -14.17% |
| 2004 Q4 | -589.1 Thousand USD | 20.79% |
| 2003 Q3 | -305.96 Thousand USD | 6.98% |
| 2003 Q1 | -396.2 Thousand USD | 55.73% |
| 2003 Q2 | -328.9 Thousand USD | 16.99% |
| 2003 FY | -1.97 Million USD | -2.68% |
| 2003 Q4 | -895.44 Thousand USD | -192.67% |
| 2002 Q2 | -293.04 Thousand USD | -32.03% |
| 2002 Q4 | -895.06 Thousand USD | -105.31% |
| 2002 Q3 | -435.94 Thousand USD | -48.76% |
| 2002 FY | -1.92 Million USD | -384.13% |
| 2002 Q1 | -221.94 Thousand USD | 0.0% |
| 2001 FY | -397.33 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | -261.11 USD | 100.0% |
| Allstar Health Brands, Inc. | -215.75 Thousand USD | 100.0% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 624.14 Million USD | 100.0% |
| Café Serendipity Holdings, Inc. | -1.43 Million USD | 100.0% |
| Health Advance Inc. | -47.57 Thousand USD | 100.0% |
| HealthWarehouse.com, Inc. | -1.62 Million USD | 100.0% |
| LIGAND PHARMACEUTICAL INC | 9.82 Million USD | 100.0% |
| MedGen, Inc. | -15.54 USD | 100.0% |
| Omni Health, Inc. | 405.52 Thousand USD | 100.0% |
| Oxford Investments Holdings Inc. | -342.3 Thousand USD | 100.0% |
| Pineapple, Inc. | -1.47 Million USD | 100.0% |
| ScripsAmerica, Inc. | -3.8 Million USD | 100.0% |